Forbion European Acquisition (FRBN) Stock Price, News & Analysis

Company Overview

Forbion European Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to identify opportunities in the life sciences industry in Europe. The company was incorporated in 2021 and is based in Wilmington, Delaware.

Key Stats

• Today's Range: $17.00 to $22.23
• 50-Day Range: $9.90 to $28.44
• 52-Week Range: $9.25 to $47.17
• Volume: 60,900 shs
• Average Volume: 140,023 shs
• Market Capitalization: $343.08 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 3/31/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: Holding & other investment offices
• Sub-Industry: N/A
• Current Symbol: NASDAQ:FRBN
• CIK: 1874495
• Web: forbion.com
• Phone: 302-273-0765
• Fax: N/A
• Employees: 2,021
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 15,810,000
• Free Float: N/A
• Market Cap: $343.08 million
• Optionable: Not Optionable
• Beta: -0.36